GOSS — Gossamer Bio Cashflow Statement
0.000.00%
Last trade - 00:00
- $176.81m
- $89.40m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -180 | -243 | -234 | -229 | -180 |
Depreciation | |||||
Non-Cash Items | 24.4 | 68.7 | 42.6 | 45 | 33.9 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 10.1 | -3.1 | 0.774 | -4.46 | -14.8 |
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Cash from Operating Activities | -145 | -176 | -189 | -187 | -159 |
Capital Expenditures | -2.97 | -1.5 | -1.55 | -0.41 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -144 | 217 | -116 | -0.625 | -111 |
Acquisition of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -147 | 215 | -117 | -1.03 | -111 |
Financing Cash Flow Items | 0 | 0 | — | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 322 | 313 | 3.33 | 117 | 190 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 29.7 | 352 | -303 | -71.5 | -79.9 |